BRCA2 and breast cancer: Germline and somatic mutations of genes involved in inherited cancer syndromes[4,5], such as BC gene 1 (BRCA1) and BC gene 2 (BRCA2), and/or related with specific morphological stages[6] and response to therapy[7-9] may influence the BC risk and its outcome.